Mercialys header image

Mercialys

MERY

Equity

ISIN FR0010241638 / Valor 2293301

Euronext - Euronext Paris (2026-01-27)
EUR 10.60+0.38%

Mercialys
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Mercialys is a leading real estate company in France and Europe, specializing in the enhancement, transformation, and promotion of shopping centers. With a portfolio of 53 sites and 844,000 sq.m of retail space, the company focuses on developing a global vision for its sites to anticipate changes in consumer buying behavior. Mercialys is implementing an ambitious development strategy centered around precision merchandising, service platforms under the "G La Galerie" identity, and modular layout designs for centers to create new retail opportunities. The company's shopping centers prioritize proximity, innovation, and local engagement, offering a unique approach to retail with a focus on creating value for all stakeholders involved.

Summarized from source with an LLMView SourceSector: Finance

Latest Results (22.01.2026):

Mercialys — full-year 2023 results (covering year ended December 31, 2023 and including Q4 2023): the company delivered resilient operating performance with net recurrent earnings (NRE) of €109.0m (+3.3%, €1.17/share), supported by +4.1% like‑for‑like organic rent growth and tight vacancy, while portfolio valuations fell (like‑for‑like -7.0%) and EPRA NDV per share declined to €17.10 (-18.4%) reflecting higher appraisal yields and marked‑to‑market revaluations of fixed‑rate debt. Management proposes a €0.99/share dividend and targets at least +2.0% NRE per share growth in 2024 with a 75–95% NRE payout range.

Profitability

Net recurrent earnings (NRE) €109.0m (+3.3% vs 2022), NRE per share €1.17 (+3.3%) — performance exceeds the ≥+2% growth target set for 2023.

Operating income and margins

Invoiced rents €177.5m (+2.8% current; +4.1% like‑for‑like). EBITDA €149.4m (+3.6%) with EBITDA margin 83.9% (vs 83.2% in 2022), reflecting strong letting and tight cost control.

Occupancy & retailer health

Current financial vacancy 2.9% (stable year‑on‑year), total vacancy 4.4%. Tenant sales +2.2% in 2023; occupancy cost ratio improved to 10.7% (from 11.1%), and rent/charges collection rate 96.3% at end‑Jan 2024.

Tenant mix / food retail realignment

Major change to food anchoring: Casino exposure economically 17.4% in 2023 but expected to be replaced progressively by Intermarché, Auchan and Carrefour (pro‑forma shares ~5.2%, 4.1% and 2.0% of rents respectively), improving rental risk profile from 2024.

Balance sheet and liquidity

Drawn debt €1,192m, cash €118m at end‑2023, LTV excl. transfer taxes 38.9%, LTV incl. transfer taxes 36.4%. Interest coverage (ICR) 5.1x — well above covenant minimums; €385m of undrawn facilities available.

Funding costs & hedging

Real average cost of drawn debt 2.3% for 2023 (up from 2.0% in 2022). Fixed‑rate debt hedging ~96% in 2023 with target to reach 100% hedging on residual debt in 2024.

Portfolio valuation and NAV metrics

Portfolio value incl. transfer taxes €2,872.0m (LFL -7.0% year). Average appraisal yield 6.61% (+86bp vs 2022). EPRA NDV €17.10/share (-18.4% year), driven by yield decompression and fair‑value impact on fixed‑rate debt.

Capital allocation & dividend

Board proposes €0.99 dividend per share for 2023 (+3.1% vs 2022), representing 85% of NRE and a 9.9% yield on 2023 year‑end closing price. 2024 dividend policy range set at 75–95% of 2024 NRE to preserve investment capacity.

Growth pipeline and M&A

Project pipeline ~€429m at end‑2023 (retail, dining/leisure, tertiary), with strict hurdle: projects must deliver ≥250bp above refinancing cost. Acquisitions in 2023 include initial stake in Imocom Partners to enhance retail‑park exposure and development capabilities.

Guidance for 2024

Targets: NRE per share growth of at least +2.0% vs 2023 and dividend payout of 75–95% of 2024 NRE. Company emphasizes selective project deployment and preservation of a sound financial structure amid higher interest rates.

Summarized from source with an LLMView Source

Key figures

2.81%1Y
3.72%3Y
46.4%5Y

Performance

21.3%1Y
24.2%3Y
27.7%5Y

Volatility

Market cap

1181 M

Market cap (USD)

Daily traded volume (Shares)

177,464

Daily traded volume (Shares)

1 day high/low

10.15 / 10.05

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

U.C.A. AG
U.C.A. AG U.C.A. AG Valor: 25364056
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.75%EUR 67.50
Accentro Real Estate AG
Accentro Real Estate AG Accentro Real Estate AG Valor: 3015724
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 75.00
Kennedy-Wilson Holdings Inc
Kennedy-Wilson Holdings Inc Kennedy-Wilson Holdings Inc Valor: 10751367
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.10%USD 9.83
Belite Bio Incorporation
Belite Bio Incorporation Belite Bio Incorporation Valor: 118450378
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.00%USD 167.34
Four Corners Property Trust Inc
Four Corners Property Trust Inc Four Corners Property Trust Inc Valor: 30202101
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 24.32
Oscar Health Inc
Oscar Health Inc Oscar Health Inc Valor: 59901290
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.22%USD 14.88
Safehold Inc
Safehold Inc Safehold Inc Valor: 125590632
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.43%USD 13.95
Arcturus Therapeutics Holdings Inc
Arcturus Therapeutics Holdings Inc Arcturus Therapeutics Holdings Inc Valor: 48461643
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.36%USD 7.46
UP Fintech Holding Ltd
UP Fintech Holding Ltd UP Fintech Holding Ltd Valor: 46662401
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.68%USD 8.81
Scholar Rock Holding Corporation
Scholar Rock Holding Corporation Scholar Rock Holding Corporation Valor: 41623961
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.00%USD 43.99